Top Markets
Coin of the day
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
Rang în acțiuni #27036
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
Preț acțiune
$2.18
Ultima sincronizare: 2026-08-19
Capitalizare de piață
$35.55M
Schimbare (1 zi)
2.57%
Schimbare (1 an)
-33.19%
Țară
US
Tranzacționează Grace Therapeutics, Inc. (GRCE)

Categorie

Istoricul spliturilor pentru Grace Therapeutics, Inc. (GRCE)
Acțiunea Grace Therapeutics, Inc. (simbol: GRCE) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 20, 2026.
O acțiune GRCE cumpărată înainte de Aug 20, 2026 este echivalentă astăzi cu 0 acțiuni GRCE.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH